206 related articles for article (PubMed ID: 12604891)
1. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis.
Katabi N; Albores-Saavedra J
Am J Surg Pathol; 2003 Mar; 27(3):349-55. PubMed ID: 12604891
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
3. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
4. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
5. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
6. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.
Hoang MP; Murakata LA; Katabi N; Henson DE; Albores-Saavedra J
Mod Pathol; 2002 Dec; 15(12):1251-8. PubMed ID: 12481004
[TBL] [Abstract][Full Text] [Related]
7. Papillary bile duct dysplasia in primary sclerosing cholangitis.
Ludwig J; Wahlstrom HE; Batts KP; Wiesner RH
Gastroenterology; 1992 Jun; 102(6):2134-8. PubMed ID: 1587434
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
9. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths.
Terada T; Nakanuma Y
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889
[TBL] [Abstract][Full Text] [Related]
10. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.
Azeem N; Gostout CJ; Knipschield M; Baron TH
Gastrointest Endosc; 2014 May; 79(5):773-779.e2. PubMed ID: 24206748
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
Layfield LJ; Cramer H
Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma.
Albores-Saavedra J; Chablé-Montero F; Méndez-Sánchez N; Mercado MÁ; Vilatoba-Chapa M; Henson DE
Hum Pathol; 2012 Dec; 43(12):2292-8. PubMed ID: 22795356
[TBL] [Abstract][Full Text] [Related]
13. [Anatomy and pathology of intrahepatic and extrahepatic bile duct tumors].
Tannapfel A; Wittekind C
Pathologe; 2001 Mar; 22(2):114-23. PubMed ID: 11321727
[TBL] [Abstract][Full Text] [Related]
14. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
16. Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.
Miura F; Asano T; Amano H; Yoshida M; Toyota N; Wada K; Kato K; Takada T; Fukushima J; Kondo F; Takikawa H
World J Gastroenterol; 2009 Mar; 15(11):1394-7. PubMed ID: 19294772
[TBL] [Abstract][Full Text] [Related]
17. Involvement of peribiliary glands in primary sclerosing cholangitis: a histopathologic study.
Terasaki S; Nakanuma Y; Unoura M; Kaneko S; Kobayashi K
Intern Med; 1997 Nov; 36(11):766-70. PubMed ID: 9392346
[TBL] [Abstract][Full Text] [Related]
18. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis.
Tokala A; Khalili K; Menezes R; Hirschfield G; Jhaveri KS
AJR Am J Roentgenol; 2014 Mar; 202(3):536-43. PubMed ID: 24555589
[TBL] [Abstract][Full Text] [Related]
19. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
20. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
